Programme
Endoscopy Live Demonstration from Prince of Wales Hospital, Hong Kong (1)
Endoscopy Live Demonstration (1) from Prince of Wales Hospital, Hong Kong
State Key Lab Meeting (1): Microbiome and Cancer
Using genetics to explore microbe-host interactions at the molecular level
Gut microbiome dynamics in MASLD: Implications for liver cancer
GUT-IDDF Young Investigator Award: Oral Presentation I
Room N102 & 3
09:00-10:30
GUT-IDDF Young Investigator Award: Oral Presentation I
Room N102 & 3
10:30-11:00
Endoscopy Live Demonstration from Prince of Wales Hospital, Hong Kong (2)
Endoscopy Live Demonstration (2) from Prince of Wales Hospital, Hong Kong
State Key Lab Meeting (2): Microbiome/Metabolites, Gut-liver Axis and Liver Diseases
GUT-IDDF Young Investigator Award: Oral Presentation II
Room N102 & 3
11:00-12:30
GUT-IDDF Young Investigator Award: Oral Presentation II
Dr S H Ho Memorial Lecture
The Obesity-GERD connection
Joseph Sung Distinguished Lecture
Morphogens, metabolism and MASLD
IBD Session (1): Advancements in IBD Management
IBD Session (1): Advancements in IBD Management
Hepatology Session (1): Viral Hepatitis
From hepatic steatosis to cancer: The role of metabolism in chronic hepatitis B
Long-term safety of oral nucleos(t)ide analogues
The road to 2030: Can Asia achieve viral hepatitis elimination?
Room N102 & 3
15:50-18:20
IBD Session (2): Cutting-Edge Issues in IBD: Advances in Imaging and Microbiome Insights
Advancements in perianal crohn's disease management: The role of ultrasound in disease monitoring and treatment efficacy
Role of gut microbiome in diagnosis and disease characterisation in IBD
Hepatology Session (2): Metabolic Dysfunction-associated Steatotic Liver Disease
Insights from recent omics studies on MASLD pathogenesis and management
Are incretin therapies the definitive solution for MASH?
** Programme last updated in March 2025